HEMATOPOIETIC STEM CELL TRANSPLANTATION
Clinical trials for HEMATOPOIETIC STEM CELL TRANSPLANTATION explained in plain language.
Never miss a new study
Get alerted when new HEMATOPOIETIC STEM CELL TRANSPLANTATION trials appear
Sign up with your email to follow new studies for HEMATOPOIETIC STEM CELL TRANSPLANTATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Potato power: simple supplement may tame deadly transplant complication
Disease control CompletedThis study tested whether a dietary supplement made from potato starch could reduce the risk of graft-versus-host disease (GVHD) in people receiving a stem cell transplant. GVHD is a serious condition where the donor cells attack the patient's body. The supplement was given to 10…
Matched conditions: HEMATOPOIETIC STEM CELL TRANSPLANTATION
Phase: PHASE2 • Sponsor: University of Michigan Rogel Cancer Center • Aim: Disease control
Last updated May 26, 2026 05:54 UTC
-
Blood cancer bleeding breakthrough? tranexamic acid trial shows promise
Disease control CompletedThis study tested whether a drug called tranexamic acid can lower the risk of serious bleeding or death in people with blood cancers who have very low platelet counts. Over 600 adults receiving chemotherapy or a stem cell transplant were randomly given either the drug or a placeb…
Matched conditions: HEMATOPOIETIC STEM CELL TRANSPLANTATION
Phase: PHASE3 • Sponsor: NHS Blood and Transplant • Aim: Disease control
Last updated May 26, 2026 05:45 UTC
-
New program boosts sexual health for stem cell transplant survivors
Symptom relief CompletedThis study tested a program to help stem cell transplant survivors who have sexual problems. About 230 adults who had a transplant at least three months earlier took part. The program aimed to improve sexual function, quality of life, and mood. Results were measured using patient…
Matched conditions: HEMATOPOIETIC STEM CELL TRANSPLANTATION
Phase: NA • Sponsor: Massachusetts General Hospital • Aim: Symptom relief
Last updated May 22, 2026 13:53 UTC
-
Fish oil emulsion shows promise for kids after bone marrow transplant
Symptom relief CompletedThis early-phase study tested whether a fish oil-based fat emulsion is safe and tolerable for 20 children undergoing stem cell transplants for cancer or blood disorders. The goal was to see if this special nutrition could reduce infections and other side effects from high-dose ch…
Matched conditions: HEMATOPOIETIC STEM CELL TRANSPLANTATION
Phase: PHASE1 • Sponsor: Alexandra N. Carey • Aim: Symptom relief
Last updated May 22, 2026 13:51 UTC
-
Real-world check on CMV drugs in transplant patients
Knowledge-focused CompletedThis study followed 400 stem cell transplant recipients to see how well anti-CMV medications work in everyday hospital care. Researchers tracked infections, drug resistance, and side effects. The goal was to improve treatment guidelines for these high-risk patients.
Matched conditions: HEMATOPOIETIC STEM CELL TRANSPLANTATION
Sponsor: University Hospital, Limoges • Aim: Knowledge-focused
Last updated May 26, 2026 05:43 UTC
-
Stem cell transplant Patients' fitness under the microscope
Knowledge-focused CompletedThis study looked at physical fitness in people who received a stem cell transplant from a donor (allogeneic transplant) and compared them to healthy individuals. Researchers measured lung function, muscle strength, balance, and quality of life in 17 transplant recipients. The go…
Matched conditions: HEMATOPOIETIC STEM CELL TRANSPLANTATION
Sponsor: Istinye University • Aim: Knowledge-focused
Last updated May 22, 2026 13:54 UTC
-
PET scans tested to guide therapy for hidden fungal infection
Knowledge-focused CompletedThis study looked at whether a special scan (PET scan) can help doctors decide the best treatment for a rare fungal infection of the liver and spleen in people with blood cancer. One hundred adults who had recently recovered from low white blood cell counts and had suspicious spo…
Matched conditions: HEMATOPOIETIC STEM CELL TRANSPLANTATION
Phase: NA • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated May 11, 2026 20:50 UTC